S 4905
118th Congress
Senate
Innovation in Pediatric Drugs Act of 2024
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Health
CancerChild healthCongressional oversightDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Drug therapyGovernment information and archivesGovernment studies and investigationsMedical researchPrescription drugsResearch administration and funding
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
Jul 31, 2024
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 4905: Innovation in Pediatric Drugs Act of 2024. 118th Congress. Open America. https://openamerica.io/bill/118-S-4905/
"S. 4905: Innovation in Pediatric Drugs Act of 2024." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-4905/.
S. 4905, 118th Cong. (2026), https://openamerica.io/bill/118-S-4905/.
[S. 4905: Innovation in Pediatric Drugs Act of 2024](https://openamerica.io/bill/118-S-4905/)